You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

unfavourable intermediate risk prostate cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Rotterdam (Adaptive radiotherapy according to UPRATE protocol)

Recruiting
  • Prostate Cancer
  • Adaptive radiotherapy according to UPRATE protocol
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Centre
Jul 26, 2022

Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,

Not yet recruiting
  • Localized Prostate Carcinoma
  • +3 more
  • Degarelix
  • MRI-guided transurethral ultrasound ablation (TULSA)
  • Turku, Southwest Finland, Finland
    Turku University Hospital
Jun 14, 2023

Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])

Not yet recruiting
  • Prostate Cancer
  • Piflufolastat F 18 Intravenous Solution [PYLARIFY]
  • (no location specified)
Oct 3, 2023

Prostate Cancer Trial in Guangzhou ([18F]Florastamin Injection)

Recruiting
  • Prostate Cancer
  • [18F]Florastamin Injection
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Aug 21, 2023

Prostate Cancer Trial in Cincinnati (Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy)

Not yet recruiting
  • Prostate Cancer
  • Apalutamide Oral Product
  • +2 more
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Mar 27, 2023

Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)

Not yet recruiting
  • Prostatic Cancer
  • High Dose Brachytherapy
  • Stereostatic Body Radiation Therapy
  • (no location specified)
Mar 3, 2023

Localized Prostate Cancer, Low Risk Prostate Cancer, Intermediate Risk Prostate Cancer Trial (3 fractions of prostate SBRT)

Not yet recruiting
  • Localized Prostate Cancer
  • +2 more
  • 3 fractions of prostate SBRT
  • (no location specified)
Oct 31, 2023

Prostate Cancer Trial in New Haven (Relugolix 120 MG [Orgovyx], SBRT standard of care radiotherapy treatment)

Not yet recruiting
  • Prostate Cancer
  • Relugolix 120 MG [Orgovyx]
  • SBRT standard of care radiotherapy treatment
  • New Haven, Connecticut
    Yale Cancer Center
Oct 26, 2023

Prostate Cancer Trial (Vanquish System)

Not yet recruiting
  • Prostate Cancer
  • Vanquish System
  • (no location specified)
Jan 16, 2023

Prostate Cancer Trial in Roma (Soractelite Echolaser Transperineal focal laser ablation)

Recruiting
  • Prostate Cancer
  • Soractelite Echolaser Transperineal focal laser ablation
  • Roma, RM, Italy
    San Carlo di Nancy Hospital
Oct 16, 2022

Prostate Cancer Trial in Chapel Hill (68Ga-HBED-CC-PSMA)

Recruiting
  • Prostate Cancer
  • Chapel Hill, North Carolina
    University of North Carolina - Chapel Hill
Jan 31, 2023

Prostate Cancer Trial in Candiolo (Robotic hemi-prostatectomy with urethral preservation)

Recruiting
  • Prostate Cancer
  • Robotic hemi-prostatectomy with urethral preservation
  • Candiolo, TO, Italy
    Fondazione del Piemonte per l'Oncologia
Apr 16, 2023

Prostate Cancer Trial in New York (IRE & MRgRT)

Recruiting
  • Prostate Cancer
  • IRE & MRgRT
  • New York, New York
    Weill Cornell Medicine
Aug 1, 2022

Prostate Cancer Trial in Rome (Decapeptyl)

Recruiting
  • Prostate Cancer
  • Rome, Lazio, Italy
  • +2 more
Sep 23, 2022

Prostate Cancer Trial in Cairo (Prostate Only Radiation, Prostate and Pelvic Lymph Node Radiation)

Recruiting
  • Prostate Cancer
  • Prostate Only Radiation
  • Prostate and Pelvic Lymph Node Radiation
  • Cairo, Egypt
    National Cancer Institute - Cairo University
Aug 9, 2022

Prostate Cancer Trial (SUPR-SABR treatment)

Not yet recruiting
  • Prostate Cancer
  • SUPR-SABR treatment
  • (no location specified)
Dec 20, 2022

Low or Intermediate Risk Prostate Cancer Trial in Toronto (Advanced imaging for radiotherapy planning and guidance)

Active, not recruiting
  • Low or Intermediate Risk Prostate Cancer
  • Advanced imaging for radiotherapy planning and guidance
  • Toronto, Ontario, Canada
    University Health Network
Oct 21, 2022

Prostate Cancer, Cancer of the Prostate Trial in Saint Louis (device, radiation, drug)

Recruiting
  • Prostate Cancer
  • Cancer of the Prostate
  • Ethos Varian treatment system
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 19, 2023

Prostate Cancer Trial in Houston (Focal Cryoablation, Standard of Care, Quality-of-life Questionnaires)

Recruiting
  • Prostate Cancer
  • Focal Cryoablation
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Jul 26, 2022

ABlative Radiotherapy (for) Unfavorable Prostate Tumors

Recruiting
  • Prostate Cancer
    • Monza, MB, Italy
      Radiation Oncology, ASST Monza (University of Milan Bicocca)
    Jul 21, 2022

    Cancer Of Prostate Trial run by the National Cancer Institute (NCI) (M9241, Stereotactic Body Radiation Therapy (SBRT))

    Recruiting
    • Cancer Of Prostate
    • M9241
    • Stereotactic Body Radiation Therapy (SBRT)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Safety and Efficacy of Two-step Radical Prostatectomy

    Recruiting
    • Prostate Cancer
    • Two-step Radical Prostatectomy
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Feb 1, 2023

    Prostate Cancer Trial in United States (Poseidon System)

    Completed
    • Prostate Cancer
    • Poseidon System
    • Baltimore, Maryland
    • +4 more
    Jul 25, 2022

    Prostate Cancer, Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen Trial in San

    Recruiting
    • Prostate Cancer
    • Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen
    • TRANBERG®|Thermal Therapy System
    • San Diego, California
      Genesis Research LLC.
    Apr 12, 2023

    Prostate Cancer Trial in Baltimore (Enoblituzumab)

    Active, not recruiting
    Has Results
    • Prostate Cancer
    • Baltimore, Maryland
      Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Aug 16, 2022